Xylem Inc（XYL）の決算・業績分析
Xylem Incの2025年有価証券報告書をAI分析。売上高$9.0B(+5.5%)。営業利益$1.2B。Industrials。
目次
Xylem Incの2025年度 業績サマリー
Xylem Inc（証券コード: XYL）の2025年度決算・業績分析。売上高は$9.0B（前年比+5.5%）。営業利益は$1.2B（前年比+21.2%）。純利益は$957M（前年比+7.5%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
Xylem Incの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- Revenue increased 6.3% YoY to $5.5B (XBRL), driven by the acquisition of Evoqua in May 2023 (10-K).
- Net income declined 16.9% YoY to $355M (XBRL), despite operating income rising 6.3% to $622M (XBRL).
- Free cash flow reached $405M (XBRL), with $269M returned to shareholders via dividends and buybacks (XBRL).
- Net debt stood at $1.2B (1.5x EBITDA) (XBRL), while liquidity remained strong with $1.0B in cash (XBRL).
- Gross margin held steady at 37.7% (XBRL), but net margin fell to 6.4% (XBRL) due to non-operating factors.
Xylem Incの売上高変化の要因
- •Total revenue grew 6.3% YoY to $5.5B (XBRL), reflecting the acquisition of Evoqua in May 2023 (10-K). The 5-year revenue CAGR was 8.2% (XBRL), but operating income CAGR declined slightly to -0.1% (XBRL). Historical data shows revenue increased from $5.0B in FY2020 to $5.5B in FY2024, with a projected jump to $7.4B in FY2025 (XBRL). Segment-specific revenue figures are not disclosed in the provided data (N/A).
Xylem Incの営業利益変化の要因
- •Gross profit was $2.1B (XBRL) with a gross margin of 37.7% (XBRL), consistent with prior years. Operating income rose 6.3% YoY to $622M (XBRL), maintaining an operating margin of 11.3% (XBRL). However, net income fell 16.9% YoY to $355M (XBRL), resulting in a net margin of 6.4% (XBRL). The 5-year net income CAGR was +2.1% (XBRL), but FY2024 marked a decline. ROE, ROA, and ROIC were 3.5%, 2.2%, and 3.0% respectively (XBRL).
Xylem Incの事業リスクと対応
Macroeconomic factors like inflation and government spending could reduce demand for products (10-K).
Geopolitical risks, including trade barriers and conflicts, may disrupt operations and supply chains (10-K).
Supply chain disruptions from tariffs, logistics, or labor shortages could impact operations (10-K).
Tax and regulatory changes may increase costs or compliance burdens (10-K).
Labor market tightness and immigration policy shifts could affect workforce availability (10-K).
Xylem Incの事業内容
Xylem Inc. designs, manufactures, and services engineered products and solutions for the global water sector, focusing on water delivery, treatment, measurement, and wastewater management (10-K). Key offerings include transport and dewatering systems, process water and wastewater treatment solutions, analytics, smart metering, digital software, and comprehensive services (10-K). The company serves water and wastewater utilities, EPC firms, and third-party contractors, with no significant customer concentration (10-K). Competitive advantages include market-leading brands, global distribution networks, a large installed base for recurring revenue, innovation history, and a commitment to sustainability (10-K). With ~23,000 employees worldwide (10-K), Xylem operates in a fragmented industry with no explicitly named competitors (10-K).
Xylem IncのAI業績分析レポート（2024年度）
Xylem Inc. (XYL) FY2024 Annual Report Analysis
Highlights
Business Overview
Xylem Inc. designs, manufactures, and services engineered products and solutions for the global water sector, focusing on water delivery, treatment, measurement, and wastewater management (10-K). Key offerings include transport and dewatering systems, process water and wastewater treatment solutions, analytics, smart metering, digital software, and comprehensive services (10-K). The company serves water and wastewater utilities, EPC firms, and third-party contractors, with no significant customer concentration (10-K). Competitive advantages include market-leading brands, global distribution networks, a large installed base for recurring revenue, innovation history, and a commitment to sustainability (10-K). With ~23,000 employees worldwide (10-K), Xylem operates in a fragmented industry with no explicitly named competitors (10-K).
Revenue Analysis
Total revenue grew 6.3% YoY to $5.5B (XBRL), reflecting the acquisition of Evoqua in May 2023 (10-K). The 5-year revenue CAGR was 8.2% (XBRL), but operating income CAGR declined slightly to -0.1% (XBRL). Historical data shows revenue increased from $5.0B in FY2020 to $5.5B in FY2024, with a projected jump to $7.4B in FY2025 (XBRL). Segment-specific revenue figures are not disclosed in the provided data (N/A).
Profitability Analysis
Gross profit was $2.1B (XBRL) with a gross margin of 37.7% (XBRL), consistent with prior years. Operating income rose 6.3% YoY to $622M (XBRL), maintaining an operating margin of 11.3% (XBRL). However, net income fell 16.9% YoY to $355M (XBRL), resulting in a net margin of 6.4% (XBRL). The 5-year net income CAGR was +2.1% (XBRL), but FY2024 marked a decline. ROE, ROA, and ROIC were 3.5%, 2.2%, and 3.0% respectively (XBRL).
Balance Sheet Analysis
Equity ratio was 63.1% (XBRL), with total equity rising to $10.2B (XBRL) in FY2024. Long-term debt was $2.3B (XBRL), resulting in a net debt of $1.2B (1.5x EBITDA) (XBRL). Current ratio was 1.76x (XBRL), and cash reserves stood at $1.0B (XBRL). Total assets grew to $16.1B (XBRL), but leverage remained moderate with a D/E ratio of 0.58x (XBRL).
Cash Flow Analysis
Operating cash flow was $596M (XBRL), with free cash flow of $405M (XBRL). Investing cash flow was -$191M (XBRL), reflecting capital expenditures and the Evoqua acquisition (10-K). Financing cash flow was -$790M (XBRL), driven by $217M in dividends (XBRL) and $52M in share repurchases (XBRL). Depreciation and amortization totaled $236M (XBRL).
Working Capital Analysis
Cash conversion cycle (CCC) was 112 days (XBRL), with receivables days at 107, inventory days at 108, and payables days at 103 (XBRL). Asset turnover was 0.34x (XBRL), indicating moderate efficiency in asset utilization.
Risks
Outlook
N/A. The 10-K does not provide explicit forward-looking guidance for FY2025 (10-K).
Historical Time Series
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | 5.0B | 5.0B | 4.7B | 5.2B | 5.5B | 7.4B |
| Operating Income | 654M | 486M | 367M | 585M | 622M | 652M |
| Net Income | 549M | 401M | 254M | 427M | 355M | 609M |
| Total Assets | 7.2B | 7.7B | 8.8B | 8.0B | 16.1B | 16.5B |
| Total Equity | 3.0B | 3.0B | 3.2B | 3.5B | 10.2B | 10.6B |
| Operating Cash Flow | 586M | 839M | 824M | 538M | 596M | 837M |
Industrialsの企業一覧
Xylem Incと同じ「Industrials」セクターの企業